Structures by: Singh S. S.
Total: 23
C10H8NO3
C10H8NO3
Journal of natural products (2018) 81, 9 1956-1961
a=6.7548(6)Å b=7.6045(6)Å c=8.7945(7)Å
α=109.9530(10)° β=90.989(2)° γ=98.977(2)°
Octa-bromo Perylenecarboxylicdianhydride
C24Br8O6,2(C4H8O)
Organic letters (2016) 18, 3 472-475
a=21.0972(18)Å b=15.0686(13)Å c=14.2085(12)Å
α=90° β=128.249(2)° γ=90°
C42H40N4O6Sn
C42H40N4O6Sn
New Journal of Chemistry (2020) 44, 15 5862-5872
a=34.4256(14)Å b=7.6022(3)Å c=14.6569(6)Å
α=90° β=99.167(6)° γ=90°
2-(2-hydroxynaphthylazo)benzoic acid
C17H12N2O3
New Journal of Chemistry (2020) 44, 15 5862-5872
a=16.5566(5)Å b=4.47010(10)Å c=19.8415(6)Å
α=90° β=111.270(7)° γ=90°
C50H58N4O8Sn2
C50H58N4O8Sn2
New Journal of Chemistry (2020) 44, 15 5862-5872
a=8.5110(3)Å b=14.2959(5)Å c=21.9517(8)Å
α=76.859(2)° β=83.682(2)° γ=73.089(2)°
C100H116N8O14Sn4,C7H8
C100H116N8O14Sn4,C7H8
New Journal of Chemistry (2020) 44, 15 5862-5872
a=12.1753(1)Å b=13.8987(1)Å c=15.6416(1)Å
α=103.640(1)° β=90.895(1)° γ=103.259(1)°
C14H10N2O5,H2O
C14H10N2O5,H2O
New J. Chem. (2016) 40, 2 1471
a=26.7027(14)Å b=3.8296(2)Å c=13.3781(7)Å
α=90° β=90° γ=90°
C36H40N4O12Sn4
C36H40N4O12Sn4
New J. Chem. (2016) 40, 2 1471
a=9.5462(3)Å b=9.7820(3)Å c=11.8061(4)Å
α=88.004(2)° β=69.650(2)° γ=79.051(2)°
Nigerloxin dioxane water solvate
C10H7NO5,0.5(C4H8O2),H2O
CrystEngComm (2016) 18, 10 1740
a=28.77(3)Å b=8.771(8)Å c=10.2110(10)Å
α=90° β=108.17(3)° γ=90°
Nigerloxin monohydrate
C10H7NO5,H2O
CrystEngComm (2016) 18, 10 1740
a=11.277(4)Å b=8.788(3)Å c=9.851(4)Å
α=90° β=96.003(7)° γ=90°
Levofloxacin hemihydrate
2(C18H20FN3O4),H2O
CrystEngComm (2014) 16, 20 4215
a=29.127(3)Å b=6.8850(2)Å c=18.8490(8)Å
α=90° β=114.089(6)° γ=90°
Levofloxacin Malonic Acid Hydrate
C18H21FN3O4,0.79(C3O4),0.21(C2O2),0.21(CO2),O
CrystEngComm (2014) 16, 20 4215
a=17.856(3)Å b=6.989(1)Å c=36.502(7)Å
α=90° β=99.282(6)° γ=90°
Levofloxacin Monohydrate
C18H20FN3O4,H2O
CrystEngComm (2014) 16, 20 4215
a=6.745(5)Å b=13.836(9)Å c=18.393(12)Å
α=90° β=95.380(11)° γ=90°
Levofloxacin Tetramethylene glutaric acid salt
C18H21FN3O4,C8.58H8O3.16,0.42(CO2)
CrystEngComm (2014) 16, 20 4215
a=18.1030(12)Å b=6.7410(4)Å c=23.9230(17)Å
α=90° β=93.800(7)° γ=90°
Levofloxacin Maleic acid salt
C18H20FN3O4,0.78(C4O4),0.22(C3O2),0.22(CO2)
CrystEngComm (2014) 16, 20 4215
a=6.830(4)Å b=34.84(2)Å c=9.908(6)Å
α=90° β=105.713(12)° γ=90°
Levofloxacin 3,5-dinitrobenzoate 1:2
C18H21FN3O4,C7H4N2O6,C7H3N2O6
CrystEngComm (2014) 16, 20 4215
a=9.135(2)Å b=12.008(3)Å c=16.533(5)Å
α=79.910(13)° β=78.135(14)° γ=73.833(13)°
6(C18H21FN3O4),3(C2O4),11(O)
6(C18H21FN3O4),3(C2O4),11(O)
CrystEngComm (2014) 16, 20 4215
a=9.984(2)Å b=17.199(3)Å c=19.058(4)Å
α=67.254(8)° β=86.503(12)° γ=77.145(11)°
C18H21FN3O4,0.5(C4O4),2(O)
C18H21FN3O4,0.5(C4O4),2(O)
CrystEngComm (2014) 16, 20 4215
a=17.06(2)Å b=6.916(7)Å c=19.12(2)Å
α=90° β=110.106(17)° γ=90°
Diisothiocyanatodihalonickelates(II)
2C24H20As,C2Br2N2NiS2
Acta Crystallographica Section E (2006) 62, 5 m1014-m1015
a=13.5382(10)Å b=15.7796(11)Å c=23.0555(16)Å
α=90.00° β=105.3470(10)° γ=90.00°
Tetraphenylarsonium diiododiisothiocyanatocobaltate(II)
2C24H20As,C2CoI2N2S22
Acta Crystallographica Section E (2006) 62, 11 m2990-m2991
a=15.699(5)Å b=13.915(4)Å c=23.465(7)Å
α=90.00° β=106.472(5)° γ=90.00°
C13H8N2O5
C13H8N2O5
Crystal Growth & Design (2015) 15, 7 3280
a=7.509(4)Å b=7.967(5)Å c=10.623(8)Å
α=75.53(3)° β=83.95(5)° γ=69.20(3)°
C13H8N2O5
C13H8N2O5
Crystal Growth & Design (2015) 15, 7 3280
a=18.94(2)Å b=5.029(6)Å c=6.071(8)Å
α=90° β=90° γ=90°
C7H5NO4
C7H5NO4
Crystal Growth & Design (2015) 15, 7 3280
a=20.98(13)Å b=5.03(3)Å c=12.85(7)Å
α=90° β=97.20(8)° γ=90°